| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.902 | 15.447 | 13.687 | 12.155 | 11.611 | 10.361 | 13.120 | 11.518 | 10.169 | 12.746 |
| Total Income - EUR | 15.902 | 15.447 | 13.687 | 12.155 | 11.611 | 10.361 | 17.163 | 11.518 | 10.169 | 12.746 |
| Total Expenses - EUR | 8.985 | 12.492 | 7.790 | 8.504 | 12.574 | 10.060 | 11.023 | 9.868 | 8.014 | 9.081 |
| Gross Profit/Loss - EUR | 6.917 | 2.954 | 5.897 | 3.650 | -963 | 301 | 6.140 | 1.650 | 2.155 | 3.664 |
| Net Profit/Loss - EUR | 6.440 | 2.491 | 5.487 | 3.286 | -1.306 | 5 | 5.625 | 1.305 | 1.543 | 2.721 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ecort Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.985 | 9.370 | 6.744 | 24.690 | 22.541 | 10.966 | 5.263 | 227 | 0 | 6.486 |
| Current Assets | 493 | 1.186 | 9.196 | 144 | 504 | 11.653 | 16.930 | 10.067 | 9.283 | 2.301 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 8.406 | 8.219 | 8.245 | 8.241 | 54 |
| Cash | 493 | 1.186 | 9.196 | 144 | 504 | 3.247 | 8.710 | 1.822 | 1.042 | 2.247 |
| Shareholders Funds | 8.801 | 10.534 | 15.842 | 18.837 | 17.167 | 16.846 | 22.098 | 9.316 | 8.742 | 3.734 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.677 | 114 | 97 | 5.997 | 5.879 | 5.773 | 95 | 978 | 541 | 5.053 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8697 - 8697" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ecort Med Srl